The largest database of trusted experimental protocols

Yohimbine hcl

Manufactured by Bio-Techne

Yohimbine HCl is a pure, crystalline alkaloid extracted from the bark of the Pausinystalia yohimbe tree. It is commonly used as a laboratory reagent and research chemical. Yohimbine HCl has physiological effects and may be used in various research applications.

Automatically generated - may contain errors

2 protocols using yohimbine hcl

1

Adrenergic Modulation of Fear Memory

Check if the same lab product or an alternative is used in the 5 most similar protocols
yohimbine HCl (Tocris) was administered in a dose (1.0mg/kg) able to potentiate fear memory consolidation (Gazarini et al., 2013 (link)). The lipophilic β-adrenoceptor antagonist propranolol HCl (10mg/kg) and the hydrophilic β-adrenoceptor antagonist nadolol (10mg/kg) were purchased from Sigma-Aldrich and used to investigate the role of central and peripheral β-adrenoceptors in the enhanced noradrenergic activity induced by yohimbine. In any case, the dose selected was able to prevent the facilitating effects of other β-adrenoceptor agonists on fear memory consolidation (Gazarini et al., 2013 (link)). Clonidine HCl (Sigma-Aldrich; 0.3mg/kg) and cannabidiol (THC-Pharma; 10mg/kg) were administered at putative memory reconsolidation-disrupting doses (Stern et al., 2012 (link), Gazarini et al., 2013 (link)). D-cycloserine (Sigma-Aldrich) was administered in a dose (15mg/kg) able to potentiate fear memory labilization (Bustos et al., 2010 (link)). All drugs were dissolved in 0.9% NaCl, except for cannabidiol, which was dissolved in NaCl 0.9% containing 5% of Tween 80® (Vetec) and administered systemically in a volume of 1.0ml/kg.
+ Open protocol
+ Expand
2

Pharmacological Modulation of Nociception

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naloxone HCl (Sigma) was prepared as a stock (50 mg/ml) in distilled water and diluted in 0.9% saline vehicle before systemic (1 mg/kg, i.p.) [26, 53] or spinal (10 µg, i.t.) [69] administration. Yohimbine HCl (Tocris) was prepared as a stock (10 mg/ml) in DMSO and diluted in 0.9 saline (30% DMSO vehicle) for spinal (30 µg, i.t.) [39] administration. S-sulpiride HCl (Sigma) was prepared as a stock (30 mg/ml) in DMSO and diluted in saline (10% DMSO vehicle) for systemic (10 mg/kg, i.p.) [9] administration. The CB1 receptor antagonist, rimonabant (SR141716A) (Tocris) was prepared as a stock in DMSO and diluted in a vehicle containing 2% tween-80 and 20% DMSO in 0.9% saline 45] for systemic administration (5 mg/kg, i.p.) [37, 73] . Sensory testing was performed 10-15 mins after systemic and spinal injections and completed within 45 min of drug treatment. The same animals underwent alternative treatment of drug or vehicle solutions separated by at least one rest day. Spinal drug treatments were followed by a 20 µl saline flush. All testing was performed blind to the treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!